Anxiety caused by a short-life hypnotic.
D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000139:chemically induced*; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged; D013375:Substance Withdrawal Syndrome; D014229:Triazolam / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; D014229:Triazolam; C020168:triazulenone